BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14648209)

  • 1. Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma.
    Bhudhisawasdi V; Muisuk K; Areejitranusorn P; Kularbkaew C; Khampitak T; Saeseow OT; Wongkham S
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):87-92. PubMed ID: 14648209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary alkaline phosphatase measured by mini-column chromatography on DEAE-cellulose: application to detection of hepatobiliary diseases.
    Yeh CT; Wei JS; Liaw YF
    Clin Chem; 1989 Aug; 35(8):1684-7. PubMed ID: 2474388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
    Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extremely high levels of alkaline phosphatase in adult patients as a manifestation of bacteremia.
    Tung CB; Tung CF; Yang DY; Hu WH; Hung DZ; Peng YC; Chang CS
    Hepatogastroenterology; 2005; 52(65):1347-50. PubMed ID: 16201071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical characterization of a high-molecular weight alkaline phosphatase in a patient with cholangiocarcinoma (alpha-1 alkaline phosphatase)].
    el-Mokhefi Z; Duvivier J; Plomteux G; Gielen J
    Ann Biol Clin (Paris); 1985; 43(3):215-20. PubMed ID: 2411171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
    Surrey LF; Frank R; Zhang PJ; Furth EE
    Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation.
    Karayannopoulou M; Polizopoulou ZS; Koutinas AF; Fytianou A; Roubies N; Kaldrymidou E; Tsioli V; Patsikas MN; Constantinidis TC; Koutinas CK
    Vet Clin Pathol; 2006 Sep; 35(3):287-90. PubMed ID: 16967410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation, diagnosis, and survival in cholangiocarcinoma: A prospective study.
    Vasilieva L; Papadhimitriou SI; Alexopoulou A; Kostopoulos I; Papiris K; Pavlidis D; Xinopoulos D; Romanos A; Dourakis SP
    Arab J Gastroenterol; 2016 Dec; 17(4):181-184. PubMed ID: 27914884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
    Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
    Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma.
    Jusakul A; Khuntikeo N; Haigh WG; Kuver R; Ioannou GN; Loilome W; Namwat N; Bhudhisawasdi V; Pugkhem A; Pairojkul C; Yongvanit P
    Asian Pac J Cancer Prev; 2012; 13 Suppl():77-82. PubMed ID: 23480749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alkaline phosphatase after extensive liver resection: a study in patients with biliary tract carcinoma.
    Nagino M; Nimura Y; Kamiya J; Kanai M; Uesaka K; Hayakawa N; Yamamoto H
    Hepatogastroenterology; 1999; 46(26):766-70. PubMed ID: 10370608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alkaline phosphatase and 5'-nucleotidase activities in patients with hepatobiliary disease.
    Belfield A
    Clin Chim Acta; 1972 Mar; 37():525-9. PubMed ID: 5022117
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative Outcome after Major Liver Resection in Jaundiced Patients with Proximal Bile Duct Cancer without Preoperative Biliary Drainage.
    Abdel Wahab M; El Hanafy E; El Nakeeb A; Hamdy E; Atif E; Sultan AM
    Dig Surg; 2015; 32(6):426-32. PubMed ID: 26372774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture.
    Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
    Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological feature of extrahepatic cholangiocarcinoma without jaundice: a single-center experience.
    Ito Y; Kenmochi T; Irino T; Egawa T; Hayashi S; Nagashima A; Kitagawa Y
    Hepatogastroenterology; 2012 Sep; 59(118):1744-7. PubMed ID: 22389267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
    Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant biliary strictures in patients with a normal bilirubin and/or normal liver enzymes.
    Thomasset SC; Saunders D; Holland A; Dennison AR; Garcea G
    HPB (Oxford); 2015 Nov; 17(11):969-74. PubMed ID: 26256123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.